National Cancer Institute Pot Clarifications
The NCI is responsible for coordinating the National Cancer Program and for maintaining our momentum in cancer research. Recent updates to their website include:
“We agree that it is the role of the U.S. Food and Drug Administration (FDA) to evaluate and approve drugs for use in the United States. We also agree that cannabis and cannabinoids should be subjected to the same rigorous scientific investigation as other drugs and medical devices to determine their effectiveness and safety.”
In the General Information section the wording was revised to make it clearer that “Cannabis is not approved by the FDA for any medical use.”
In the General Information section, a sentence was replaced to add clarification. The CAM Editorial Board realized that the previous wording could have been misinterpreted as being a recommendation for prescribing Cannabis, which was not the intent of the Board.
In addition, the current evidence for the antitumor properties of Cannabi is discussed only in the context of laboratory studies and not in research involving humans.